Live feed
Filing
SC 13D/A
SC 13D/A0001193125-16-718406·Carisma Therapeutics Inc.
Schedule 13D ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: 2016-09-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-718406
- Form type
- SC 13D/A
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Sep 23, 2016
- Reporting period
- Sep 21, 2016
- Description
- Schedule 13D beneficial ownership